Jonathan Schechter - Net Worth and Insider Trading
Jonathan Schechter Net Worth
The estimated net worth of Jonathan Schechter is at least $74,291 dollars as of 2024-09-20. Jonathan Schechter is the Director of Neurotrope Inc and owns about 75,000 shares of Neurotrope Inc (NTRP) stock worth over $70,575. Jonathan Schechter is also the Director of Synaptogenix Inc and owns about 1,140 shares of Synaptogenix Inc (SNPX) stock worth over $3,716. Details can be seen in Jonathan Schechter's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jonathan Schechter has not made any transactions after 2022-12-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jonathan Schechter
Jonathan Schechter Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jonathan Schechter owns 6 companies in total, including Neurotrope Inc (NTRP) , AYRO Inc (AYRO) , and Protagenic Therapeutics Inc (PTIX) among others .
Click here to see the complete history of Jonathan Schechter’s form 4 insider trades.
Insider Ownership Summary of Jonathan Schechter
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTRP | Neurotrope Inc | 2020-10-30 | director |
| AYRO | AYRO Inc | 2017-03-30 | director |
| PTIX | Protagenic Therapeutics Inc | 2014-09-02 | director |
 | | 2022-12-16 | director |
| | 2022-08-15 | director |
| | 2023-05-29 | director |
Jonathan Schechter Latest Holdings Summary
Jonathan Schechter currently owns a total of 2 stocks. Among these stocks, Jonathan Schechter owns 75,000 shares of Neurotrope Inc (NTRP) as of October 30, 2020, with a value of $70,575 and a weighting of 95%. Jonathan Schechter also owns 1,140 shares of Synaptogenix Inc (SNPX) as of December 16, 2022, with a value of $3,716 and a weighting of 5%.
Latest Holdings of Jonathan Schechter
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTRP | Neurotrope Inc | 2020-10-30 | 75,000 | 0.94 | 70,575 |
| SNPX | Synaptogenix Inc | 2022-12-16 | 1,140 | 3.26 | 3,716 |
Holding Weightings of Jonathan Schechter
Jonathan Schechter Form 4 Trading Tracker
According to the SEC Form 4 filings, Jonathan Schechter has made a total of 3 transactions in Neurotrope Inc (NTRP) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Neurotrope Inc is the acquisition of 25,000 shares on October 30, 2020, which cost Jonathan Schechter around $24,500.
According to the SEC Form 4 filings, Jonathan Schechter has made a total of 1 transactions in Synaptogenix Inc (SNPX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Synaptogenix Inc is the sale of 810 shares on December 16, 2022, which brought Jonathan Schechter around $23,693.
Insider Trading History of Jonathan Schechter
- 1
Jonathan Schechter Trading Performance
GuruFocus tracks the stock performance after each of Jonathan Schechter's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jonathan Schechter is %. GuruFocus also compares Jonathan Schechter's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jonathan Schechter within 3 months outperforms times out of transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jonathan Schechter's insider trading performs compared to the benchmark.
Performance of Jonathan Schechter
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.74 | | | | | |
| Relative Return to S&P 500(%) | -15.51 | | | | | |
Jonathan Schechter Ownership Network
Jonathan Schechter Owned Company Details
What does Neurotrope Inc do?
Who are the key executives at Neurotrope Inc?
Jonathan Schechter is the director of Neurotrope Inc. Other key executives at Neurotrope Inc include director & Chief Executive Officer Charles S. Ryan , COO and General Counsel Michael Ciraolo , and See Remarks Robert Weinstein .
Neurotrope Inc (NTRP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Neurotrope Inc (NTRP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurotrope Inc (NTRP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Neurotrope Inc (NTRP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neurotrope Inc Insider Transactions
Jonathan Schechter Mailing Address
Above is the net worth, insider trading, and ownership report for Jonathan Schechter. You might contact Jonathan Schechter via mailing address: C/o Atrinsic, Inc. 1 Grand Central Place, Suite 2319, New York Ny 10165.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
